Therapeutic pyrazolyl thienopyridines
US9260450B2 · kind B2 · utility
1Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2015 |
| Grant date | Feb 16, 2016 |
| Priority date | — |
| Expiry date | Mar 3, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4365
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides for compounds of Formula I, and pharmaceutically acceptable salts thereof,wherein R1, R2, R3, R4, R5, R6, and R7 have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as therapeutic agents in the treatment of TGFβ-mediated conditions, including cancer and fibrotic disorders. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.